levofloxacin has been researched along with Chronic Disease in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (11.76) | 18.2507 |
| 2000's | 30 (44.12) | 29.6817 |
| 2010's | 24 (35.29) | 24.3611 |
| 2020's | 6 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Burns, JL; Dudley, MN; Griffith, DC; King, P; Lomovskaya, O | 1 |
| Gong, WT; He, Q; Qin, Y; Song, NH; Tang, LL; Yang, M; Ye, HS; Zhang, W | 1 |
| Gudima, IA; Ibishev, KS; Ismailov, RS; Kogan, MI; Naboka, YL | 1 |
| Griffith, DC; Sabet, M | 1 |
| Chen, JQ; Cheng, JL; Liao, XH; Wang, F; Wu, JT | 1 |
| Pliska, NN | 1 |
| Abel, K; Ayers, GD; Baughman, RP; Bernard, GR; Crouser, ED; Culver, DA; Ding, T; Drake, WP; Green, A; James, WE; Judson, MA; Kerrigan, A; Sesay, A | 1 |
| Arcaniolo, D; Calace, FP; Creta, M; Crocetto, F; De Sio, M; Fusco, F; Giordano, D; Manfredi, C; Quattrone, C | 1 |
| Cho, KS; Kim, JW; Kim, SD | 1 |
| Chen, G; Chen, H; Chen, J; Li, T; Ouyang, L; Wang, X; Xiang, J; Zhang, S | 1 |
| Chang, DG; Dai, XH; Guo, Y; Li, J; Wang, X; Wang, Y; Xiong, W; Yany, XZ; Zhang, PH | 1 |
| Luo, SB; Meng, ZC; Zhang, JY; Zhang, XY | 1 |
| Božić, DD; Ćirković, I; Čolović, J; Jotić, A; Milovanović, J; Pavlović, B | 1 |
| Kaufmann, M; Knabbe, C; Seibold, E; Splettstoesser, W; Weile, J | 1 |
| Aboud, C; Algood, H; Boyd, AS; Braun, N; Burke, VE; Drake, WP; Isom, J; Kaminski, N; King, LE; Oswald-Richter, K; Pandit, KV; Richmond, BW; Taylor, T; Yu, C | 1 |
| Popov, SV | 1 |
| Ampofo, K; Hillyard, B; Sherwin, CM; Spigarelli, MG; Stockmann, C | 1 |
| Meizoso-Latova, T; Morales-Conejo, M; Moreno-Cuerda, VJ; Ruiz-Galiana, J | 1 |
| Aaron, SD; Bell, SC; Conrad, D; Dudley, MN; Fischer, R; Flume, PA; Geller, DE; Kerem, E; Loutit, JS; Morgan, EE; Smyth, AR; Stuart Elborn, J; VanDevanter, DR | 1 |
| Castiglione, R; Mazzarino, MC; Salemi, M; Vicari, BO; Vicari, E; Vicari, LO | 1 |
| Liang, K; Wang, J; Xu, Z; Yan, D | 1 |
| Aaron, SD; Bell, SC; Conrad, D; Dudley, MN; Elborn, JS; Fischer, R; Flume, PA; Geller, DE; Kerem, E; Loutit, JS; Morgan, EE; Smyth, AR; VanDevanter, DR | 1 |
| Fan, F; Hu, R; Jin, X; Zhang, F; Zhao, Y | 1 |
| Bartoletti, R; Cai, T; Gallelli, L; Malossini, G; Mirone, V; Palmieri, A; Tiscione, D; Verze, P | 1 |
| Chen, C; Gu, H; He, X; Huang, W; Jiang, J; Li, J; Liu, W; Wang, Q; Zhang, D; Zhou, N | 1 |
| Andryukhin, MI; Mazina, SE; Nikolaev, AL; Talberg, PI | 1 |
| Botto, H; Naber, KG; Roscher, K; Schaefer, V | 1 |
| Fokkens, WJ; Reitsma, JB; van Drunen, CM; Videler, WJ | 1 |
| He, L; Kampik, A; Kreutzer, TC; Mino de Kaspar, H; Nentwich, MM; Ta, CN; Yactayo-Miranda, Y | 1 |
| Abuzeid, WM; Chiu, AG; Doghramji, L; Edelstein, PH; Guss, J | 1 |
| Dudley, MN; Griffith, DC; Lomovskaya, O; Sabet, M; Tarazi, Z; Tsivkovskii, R | 1 |
| Naber, KG; Roscher, K; Wagenlehner, F | 1 |
| Antoniu, SA; Azoicai, D | 1 |
| Chao, WF; Huang, XK; Liang, P; Liu, JW; Wang, L; Wang, QT; Yang, H; Yang, W; Zhou, P | 1 |
| Zuck, P | 1 |
| Istomin, EA; Mokrousov, IV; Narvskaia, OV; Otten, TF; Vishnevskiĭ, BI | 1 |
| Shen, M; Zhao, Y; Zhou, LQ | 1 |
| Cho, YH; Choi, YJ; Hwang, TK; Kim, JC; Lee, SJ; Seo, SI; SW, SW | 1 |
| Bundrick, W; Heron, SP; Kahn, JB; Ray, P; Schiff, WM; Tennenberg, AM; Wiesinger, BA; Wright, PA; Wu, SC; Zadeikis, N | 1 |
| Barkin, J; Brock, G; Casey, RW; Clark, J; Downey, J; Flax, S; Goldfarb, B; Nickel, JC; Palmer, BW; Patrick, AB; Pommerville, PJ; Steinhoff, G; Zadra, J | 1 |
| Blasi, F | 1 |
| Fogarty, C; Fulambarker, A; Sethi, S | 1 |
| Brumpt, I; Veyssier, P; Zuck, P | 1 |
| Davydova, IV; Katosova, LK; Kliukina, LP; Shcherbakova, NIu; Volkov, IK | 1 |
| Ambruzs, ME; Fisher, AC; Grossman, RF; Martinez, FJ; Tennenberg, AM; Walker, K; Zadeikis, N | 1 |
| Kahn, JB; Schaeffer, AJ; Tennenberg, AM; Wu, SC | 1 |
| Artemenko, N; Gorelov, A; Perekalina, T; Smelov, V; Smelova, N; Ukleeva, G | 1 |
| Ascione, T; Esposito, S; Gaeta, GB; Ianniello, F; Leone, S; Noviello, S | 1 |
| Adebayo, SA; Olapade-Olaopa, EO | 1 |
| Ambrusz, ME; Fisher, AC; Grossman, RF; Kahn, JB; Khashab, MM | 1 |
| Bottin, R; Furlanut, M; Marioni, G; Pavan, F; Pea, F; Staffieri, A; Staffieri, C | 1 |
| Cai, X; Huang, YF; Shang, XJ; Teng, WH; Xu, H | 1 |
| Konishi, I; Kumata, M; Yamamoto, A | 1 |
| Barbone, F; De Maria, M; Giannarini, G; Manassero, F; Mogorovich, A; Morelli, G; Selli, C; Valent, F | 1 |
| Guo, DF; Wang, HP; Zhang, HZ | 1 |
| Odagiri, S | 1 |
| Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R | 1 |
| Ariza, H; Ascoli, M; Casellas, JM; Dolmann, A; Gilardoni, M; Goldberg, M; Ivanovic, S; Montero, JM; Orduna, M; Tome, G | 1 |
| Davies, BI; Maesen, FP | 1 |
| Greenberg, RN; Newman, MT; Pectol, RW; Shariaty, S | 1 |
| Fujita, A; Goya, T; Hirayama, S; Isaka, H; Koshiishi, Y; Miya, T; Ono, Y; Tanaka, R | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Shah, PM | 1 |
| Li-McLeod, J; Perfetto, EM | 1 |
| Budanov, SV; Smirnova, LB; Vasil'ev, AN | 1 |
| Nakamori, Y; Nakata, K; Nakatani, T; Narui, K; Sugi, H; Tsuboi, E | 1 |
| Horiba, M; Suzuki, K | 1 |
6 review(s) available for levofloxacin and Chronic Disease
| Article | Year |
|---|---|
[Rational antimicrobial therapy of chronic bacterial prostatitis].
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Staphylococcal Infections; Staphylococcus; Treatment Outcome | 2013 |
Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chronic Disease; Cystic Fibrosis; Humans; Levofloxacin; Lung; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Time Factors; Treatment Outcome | 2015 |
MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Chronic Disease; Clinical Trials as Topic; Drug Discovery; Drug Resistance, Bacterial; Humans; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Treatment Outcome | 2013 |
Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Treatment Outcome | 2004 |
The use of levofloxacin in the treatment of respiratory tract infection.
Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Urinary Tract Infections | 2001 |
30 trial(s) available for levofloxacin and Chronic Disease
| Article | Year |
|---|---|
[Linshu Decoction combined with levofloxacin for lower urinary tract symptoms in patients with type ⅢA prostatitis].
Topics: Chronic Disease; Humans; Levofloxacin; Lower Urinary Tract Symptoms; Male; Medicine, Chinese Traditional; Prostatitis | 2020 |
[Extended culture study as a keypoint to rethinking antibiotic therapy for chronic bacterial prostatitis].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Humans; Levofloxacin; Male; Prostatitis | 2023 |
[Medication versus health education for patients with type Ⅲ prostatitis-like symptoms: A prospective randomized control study].
Topics: Adrenergic alpha-1 Receptor Antagonists; Chronic Disease; Humans; Levofloxacin; Male; Patient Education as Topic; Prospective Studies; Prostatitis; Quality of Life; Tamsulosin; United States; Urological Agents | 2019 |
Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Levofloxacin; Male; Middle Aged; Respiratory Function Tests; Rifabutin; Sarcoidosis, Pulmonary | 2021 |
Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Escherichia coli; Humans; Levofloxacin; Male; Middle Aged; Prostatitis; Treatment Outcome; Young Adult | 2021 |
[Acupuncture combined with western medicine for CP/CPPS:a randomized controlled trial].
Topics: Acupuncture Points; Acupuncture Therapy; Chronic Disease; Chronic Pain; Combined Modality Therapy; Humans; Levofloxacin; Male; Pelvic Pain; Prostatitis; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2016 |
[Traditional Chinese medicine fumigation combined with Levofloxacin for type ⅢA prostatitis with the symptoms of damp heat and blood stasis].
Topics: Anti-Bacterial Agents; Chronic Disease; Drugs, Chinese Herbal; Fumigation; Hot Temperature; Humans; Levofloxacin; Male; Medicine, Chinese Traditional; Prostatitis; Severity of Illness Index; Symptom Assessment | 2017 |
[Triple acupuncture at the Qugu acupoint as an adjunctive therapy for type-Ⅲ chronic prostatitis: Analysis of short- and long-term clinical effects].
Topics: Acupuncture Points; Acupuncture Therapy; Anti-Bacterial Agents; Chronic Disease; Chronic Pain; Combined Modality Therapy; Drug Therapy, Combination; Humans; Levofloxacin; Male; Pelvic Pain; Prazosin; Prostatitis; Quality of Life; Recurrence; Syndrome; United States; Urological Agents | 2017 |
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Azithromycin; CD4-Positive T-Lymphocytes; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Sarcoidosis; Severity of Illness Index; Single-Blind Method; Skin Diseases; Transcriptome; Treatment Outcome; Young Adult | 2013 |
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Levofloxacin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Tobramycin; Treatment Outcome; Young Adult | 2015 |
A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chronic Disease; Drug Therapy, Combination; Humans; Levofloxacin; Male; Pelvic Pain; Prazosin; Prospective Studies; Prostatitis; Syndrome; Treatment Outcome; Urological Agents | 2016 |
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Cystic Fibrosis; Double-Blind Method; Drug Monitoring; Female; Forced Expiratory Volume; Humans; Levofloxacin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Symptom Assessment; Symptom Flare Up; Treatment Outcome | 2016 |
Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
Topics: Adult; Anti-Bacterial Agents; Bromelains; Carotenoids; Chronic Disease; Dimethyl Sulfoxide; Drug Therapy, Combination; Follow-Up Studies; Humans; Levofloxacin; Lycopene; Male; Plant Extracts; Prospective Studies; Prostatitis; Selenium; Serenoa; Sulfones; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2016 |
Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2008 |
Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Chronic Disease; Colistin; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Nebulizers and Vaporizers; Ofloxacin; Pilot Projects; Rhinitis; Sinusitis; Staphylococcal Infections; Staphylococcus aureus | 2008 |
A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.
Topics: Administration, Topical; Anti-Bacterial Agents; Blepharitis; Chronic Disease; Colony Count, Microbial; Conjunctiva; Conjunctivitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome | 2009 |
[Efficacy of compound Xuanju capsule in the treatment of chronic prostatitis with erectile dysfunction].
Topics: Adult; Capsules; Chronic Disease; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Phytotherapy; Prazosin; Prostatitis; Treatment Outcome; Young Adult | 2012 |
Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2003 |
Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pelvic Pain; Pilot Projects; Prostatitis; Safety; Treatment Outcome | 2003 |
A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gemifloxacin; Humans; Levofloxacin; Male; Middle Aged; Naphthyridines; Ofloxacin; Treatment Outcome | 2004 |
[Efficacy of levofloxacin (Tavanic) in the treatment of children with chronic pulmonary diseases].
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Humans; Injections, Intravenous; Levofloxacin; Ofloxacin | 2004 |
Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis, Chronic; Chronic Disease; Cost-Benefit Analysis; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nausea; Ofloxacin; Patient Selection; Streptococcus pneumoniae; Treatment Outcome | 2005 |
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2005 |
Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Ofloxacin | 2006 |
[Longqingpian combined with levofloxacin highly effective for type IIIA prostatitis].
Topics: Adult; Chronic Disease; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Phytotherapy; Prostatitis | 2007 |
Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Dioxolanes; Double-Blind Method; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Piperazines; Prospective Studies; Prostatitis; Quinolones | 2007 |
[Yiqigushen capsule combined with levofloxacin highly effective for type III A prostatitis].
Topics: Adult; Anti-Infective Agents, Urinary; Capsules; Chronic Disease; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Levofloxacin; Male; Medicine, Chinese Traditional; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2008 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 1999 |
Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Streptococcus pneumoniae; Treatment Outcome | 1999 |
Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Osteomyelitis; Quinolones | 2000 |
32 other study(ies) available for levofloxacin and Chronic Disease
| Article | Year |
|---|---|
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
Topics: Aerosols; Anti-Bacterial Agents; Bacteria; Biofilms; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Cystic Fibrosis; Humans; Levofloxacin; Lung Diseases; Microbial Sensitivity Tests; Ofloxacin; Sputum | 2010 |
Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Chronic Disease; Cystic Fibrosis; Female; Humans; Levofloxacin; Lung; Mice; Mice, Inbred BALB C; Respiratory Tract Infections | 2020 |
Pseudomonas Aeruginosa as the Main Causative Agent of Osteomyelitis and its Susceptibility to Antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Doripenem; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2020 |
A pigmented lesion of the nasopharynx.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Chronic Disease; Diagnosis, Differential; Female; Humans; Laryngoscopy; Levofloxacin; Nasopharyngitis; Nasopharynx; Necrosis; Pigmentation; Treatment Outcome; Ulcer | 2017 |
Antibiofilm effects of amoxicillin-clavulanic acid and levofloxacin in patients with chronic rhinosinusitis with nasal polyposis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Biofilms; Chronic Disease; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Rhinitis; Sinusitis | 2018 |
Treatment of tularemia in patient with chronic graft-versus-host disease.
Topics: Anti-Bacterial Agents; Chronic Disease; Doxycycline; Francisella tularensis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Tularemia | 2013 |
[Xanthogranulomatous pyelonephritis with cutaneous fistula and a right flank mass].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Cutaneous Fistula; Drainage; Escherichia coli Infections; Female; Humans; Kidney Calculi; Levofloxacin; Pyelonephritis, Xanthogranulomatous; Radiography; Urinary Fistula | 2015 |
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chlamydia; Chronic Disease; Humans; Infertility, Male; Interleukin-6; Italy; Leukocyte Count; Levofloxacin; Male; Prostatitis; Reactive Oxygen Species; Semen; Sperm Motility; Treatment Outcome; Tumor Necrosis Factor-alpha; Viscosity; Young Adult | 2016 |
A treatment method for chronic suppurative lacrimal canaliculitis using chalazion forceps.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Canaliculitis; Chronic Disease; Curettage; Female; Humans; Intubation; Levofloxacin; Male; Middle Aged; Ophthalmologic Surgical Procedures; Prospective Studies; Suppuration; Surgical Instruments; Therapeutic Irrigation; Young Adult | 2016 |
Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects.
Topics: Absorbable Implants; Animals; Bone and Bones; Bone Regeneration; Chronic Disease; Disease Models, Animal; Durapatite; Immunohistochemistry; Levofloxacin; Microspheres; Nanoparticles; Osteomyelitis; Polyurethanes; Rabbits; Radiography; Silicon Dioxide; Tissue Scaffolds; X-Ray Microtomography | 2017 |
[Ultrasound physiotherapy treatment of prostatitis].
Topics: Animals; Anti-Bacterial Agents; Bacteria; Chronic Disease; Humans; Immunomodulation; Levofloxacin; Male; Physical Therapy Modalities; Prostatitis; Rats; Rats, Wistar; Time Factors; Tissue Distribution; Ultrasonic Therapy | 2016 |
Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Outpatients; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Rhinitis; Sinusitis; Surgical Wound Infection | 2009 |
Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Anti-Inflammatory Agents; Cell Line; Chronic Disease; Epithelial Cells; Gene Expression Profiling; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Ofloxacin; Pneumonia; Tobramycin | 2011 |
[Practice management of chronic bacterial prostatitis with levofloxacin].
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Chronic Disease; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis; Recurrence; Staphylococcal Infections | 2011 |
[Update on the use of levofloxacin in the management of acute exacerbations of chronic bronchitis with risk factors].
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chronic Disease; Drug Resistance; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Care Planning; Recurrence; Risk Factors | 2002 |
[Sensitivity to levofloxacin of Mycobacterium tuberculosis strains with various phenotype isolated from patients with newly diagnosed and chronic tuberculosis].
Topics: Anti-Infective Agents; Chronic Disease; Drug Resistance, Bacterial; Genotype; Humans; Levofloxacin; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 2002 |
[Detection of bacterial 16S rRAN gene in EPS of men with chronic pelvic pain syndrome and its clinical significance].
Topics: Anti-Bacterial Agents; Azithromycin; Chronic Disease; Humans; Levofloxacin; Male; Ofloxacin; Pelvic Pain; Polymerase Chain Reaction; Prostatitis; RNA, Bacterial; RNA, Ribosomal, 16S | 2003 |
Effects of androgen deprivation on chronic bacterial prostatitis in a rat model.
Topics: Androgen Antagonists; Animals; Anti-Infective Agents, Urinary; Castration; Chronic Disease; Enzyme Inhibitors; Escherichia coli Infections; Estradiol; Estrogens; Finasteride; Levofloxacin; Male; Models, Animal; Ofloxacin; Prostatitis; Random Allocation; Rats; Rats, Wistar; Testosterone | 2003 |
[Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors].
Topics: Acute Disease; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Humans; Levofloxacin; Ofloxacin; Risk Factors | 2004 |
Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Chronic Disease; Fluoroquinolones; Humans; Levofloxacin; Male; Ofloxacin; Prostatitis; Quinolones | 2005 |
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofloxacin; Liver Diseases; Male; Middle Aged; Ofloxacin; Peritonitis; Pneumonia; Prospective Studies; Urinary Tract Infections | 2006 |
Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Levofloxacin; Male; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2006 |
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.
Topics: Adult; Aged; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Levofloxacin; Male; Middle Aged; Mucous Membrane; Ofloxacin; Paranasal Sinuses; Rhinitis; Sinusitis | 2007 |
[Drug-resistant bacteria isolated from pharyngeal swab cultures and urine in acutely or chronically febrile elderly nursing home inmates].
Topics: Acute Disease; Aged; Chronic Disease; Drug Resistance, Bacterial; Escherichia coli; Fever; Fluoroquinolones; Humans; Levofloxacin; Nursing Homes; Ofloxacin; Penicillin Resistance; Pharynx; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections; Urine | 2007 |
Levofloxacin in patients with severe respiratory tract infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections | 1995 |
Sparfloxacin and levofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones | 1997 |
Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Community-Acquired Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Ofloxacin; Penicillin Resistance; Pneumonia, Bacterial; Pseudomonas aeruginosa; Streptococcus pneumoniae | 1999 |
[Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint].
Topics: Adult; Aged; Chronic Disease; Female; Humans; Levofloxacin; Lung; Male; Middle Aged; Ofloxacin; Pneumonia; Respiratory Tract Infections; Saliva; Time Factors | 1999 |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2000 |
Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.
Topics: Absenteeism; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Chronic Disease; Cost of Illness; Cost-Benefit Analysis; Efficiency; Employer Health Costs; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; United States | 2001 |
[Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections].
Topics: Aged; Chronic Disease; Drug Evaluation; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections; Sputum | 1992 |
[Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis].
Topics: Adult; Aged; Chronic Disease; Drug Administration Schedule; Epididymitis; Escherichia coli; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcus; Urinary Tract Infections | 1992 |